| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...855281V |
| P356 | DOI | 10.1371/JOURNAL.PONE.0055281 |
| P932 | PMC publication ID | 3572119 |
| P698 | PubMed publication ID | 23418438 |
| P5875 | ResearchGate publication ID | 235650570 |
| P50 | author | Nicolas Vignier | Q58842005 |
| Isabelle Nelson | Q42695224 | ||
| Gisèle Bonne | Q47352548 | ||
| P2093 | author name string | David Israeli | |
| Lucie Carrier | |||
| Thomas Voit | |||
| Sabine Charrier | |||
| Laurent Servais | |||
| Isabelle Richard | |||
| Michel Arock | |||
| Jérôme Poupiot | |||
| Paul Fogel | |||
| Marie Montus | |||
| Angélique Duvallet | |||
| Fatima Amor | |||
| P2860 | cites work | Microvascular Function Is Selectively Impaired in Patients With Hypertrophic Cardiomyopathy and Sarcomere Myofilament Gene Mutations | Q57841011 |
| MicroRNA expression profiling in patients with lamin A/C-associated muscular dystrophy | Q58476852 | ||
| Mouse model carrying H222P- Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies | Q60535383 | ||
| MicroRNAs Involved in Molecular Circuitries Relevant for the Duchenne Muscular Dystrophy Pathogenesis Are Controlled by the Dystrophin/nNOS Pathway | Q62722983 | ||
| The muscular dystrophies | Q77731754 | ||
| MicroRNA-206 is overexpressed in the diaphragm but not the hindlimb muscle of mdx mouse | Q80218647 | ||
| Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy | Q81943384 | ||
| Serum microRNAs are promising novel biomarkers | Q21144238 | ||
| Secretory mechanisms and intercellular transfer of microRNAs in living cells | Q24603413 | ||
| miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy | Q24608004 | ||
| MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease | Q24608809 | ||
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| A mammalian microRNA expression atlas based on small RNA library sequencing | Q24644709 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| Distinctive patterns of microRNA expression in primary muscular disorders | Q24675407 | ||
| Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? | Q26992023 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases | Q28131780 | ||
| Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice | Q28251438 | ||
| Cardiac myosin binding protein C gene is specifically expressed in heart during murine and human development | Q28259741 | ||
| Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma | Q29614238 | ||
| Characterization of microRNA expression profiles in normal human tissues | Q29615492 | ||
| MicroRNA-378 targets the myogenic repressor MyoR during myoblast differentiation | Q30426550 | ||
| Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy | Q30498939 | ||
| A novel and universal method for microRNA RT-qPCR data normalization | Q33468633 | ||
| Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice | Q33838074 | ||
| Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy | Q33867329 | ||
| "Laminopathies": a wide spectrum of human diseases | Q34242119 | ||
| Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies | Q34291952 | ||
| MicroRNAs accurately identify cancer tissue origin | Q34764379 | ||
| Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia | Q34986949 | ||
| Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex | Q35532947 | ||
| Genetics of inherited cardiomyopathy. | Q35721684 | ||
| Molecular and cell biology of the sarcoglycan complex | Q36152977 | ||
| Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice | Q36276730 | ||
| Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin | Q36290630 | ||
| Creatine kinase: a review of its use in the diagnosis of muscle disease. | Q36346293 | ||
| Hereditary muscular dystrophies and the heart | Q37772311 | ||
| Circulating microRNAs: Association with disease and potential use as biomarkers | Q37818867 | ||
| Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? | Q37981140 | ||
| The role of cytoskeletal proteins in cardiomyopathies | Q41713568 | ||
| miRNAs as serum biomarkers for Duchenne muscular dystrophy | Q42126374 | ||
| miRNA expression in the failing human heart: functional correlates | Q43124379 | ||
| N-terminal Pro brain natriuretic peptide is a reliable biomarker of reduced myocardial contractility in patients with lamin A/C gene mutations | Q48129441 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e55281 | |
| P577 | publication date | 2013-02-13 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Distinctive serum miRNA profile in mouse models of striated muscular pathologies | |
| P478 | volume | 8 |
| Q28611318 | 204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The Netherlands |
| Q48543939 | 226th ENMC International Workshop:: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20-22 January 2017, Heemskerk, The Netherlands |
| Q37238936 | Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy |
| Q64981767 | An AAV-SGCG Dose-Response Study in a γ-Sarcoglycanopathy Mouse Model in the Context of Mechanical Stress. |
| Q47727907 | Antigenicity analysis of human parvovirus B19-VP1u protein in the induction of anti-phospholipid syndrome |
| Q35106915 | Assessment of RT-qPCR normalization strategies for accurate quantification of extracellular microRNAs in murine serum |
| Q38793915 | Atomic force microscopy and lamins: A review study towards future, combined investigations |
| Q37610530 | Circulating Biomarkers for Duchenne Muscular Dystrophy. |
| Q97423855 | Circulating Biomarkers in Muscular Dystrophies: Disease and Therapy Monitoring |
| Q42209543 | Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies |
| Q49376536 | Circulating myomiRs: a new class of biomarkers to monitor skeletal muscle in physiology and medicine. |
| Q58767734 | Comprehensive RNA-Sequencing Analysis in Serum and Muscle Reveals Novel Small RNA Signatures with Biomarker Potential for DMD |
| Q92727048 | Cross-sectional study into age-related pathology of mouse models for limb girdle muscular dystrophy types 2D and 2F |
| Q40150738 | Decreased myoblast differentiation in chronic binge alcohol-administered simian immunodeficiency virus-infected male macaques: role of decreased miR-206. |
| Q38895005 | Detection and quantification of extracellular microRNAs in murine biofluids. |
| Q26864093 | Does regulation of skeletal muscle function involve circulating microRNAs? |
| Q35055089 | Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy |
| Q26770102 | Epigenetic Reprogramming of Muscle Progenitors: Inspiration for Clinical Therapies |
| Q64898517 | Extracellular microRNAs exhibit sequence-dependent stability and cellular release kinetics. |
| Q39053709 | Frontier impact of microRNAs in skeletal muscle research: a future perspective |
| Q35998011 | Grazing Affects Exosomal Circulating MicroRNAs in Cattle |
| Q36875975 | Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach |
| Q90348872 | Influence of microRNAs and exosomes in muscle health and diseases |
| Q42719076 | Laminin α2 Chain-Deficiency is Associated with microRNA Deregulation in Skeletal Muscle and Plasma |
| Q33810713 | Mega roles of microRNAs in regulation of skeletal muscle health and disease |
| Q27321524 | MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis |
| Q64241427 | MicroRNA-672-5p Identified during Weaning Reverses Osteopenia and Sarcopenia in Ovariectomized Mice |
| Q26778555 | MicroRNAs Based Therapy of Hypertrophic Cardiomyopathy: The Road Traveled So Far |
| Q52562166 | MicroRNAs in hereditary and sporadic premature aging syndromes and other laminopathies. |
| Q36584640 | Muscle-specific microRNAs as biomarkers of Duchenne Muscular Dystrophy progression and response to therapies |
| Q38850158 | Non-coding RNAs in muscle differentiation and musculoskeletal disease. |
| Q50479884 | Noncoding RNAs and Duchenne muscular dystrophy. |
| Q26996781 | Noncoding RNAs: emerging players in muscular dystrophies |
| Q55366811 | Phenotype-Specific Response of Circulating miRNAs Provides New Biomarkers of Slow or Fast Muscle Damage. |
| Q52595135 | Role of miR-200c in Myogenic Differentiation Impairment via p66Shc: Implication in Skeletal Muscle Regeneration of Dystrophic mdx Mice. |
| Q28817525 | Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation |
| Q59532173 | Serum microRNA profiles in cats with hypertrophic cardiomyopathy |
| Q35924068 | Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies. |
| Q37183460 | Skeletal Muscle MicroRNAs: Their Diagnostic and Therapeutic Potential in Human Muscle Diseases |
| Q36590389 | TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy |
| Q58556997 | The Role of MicroRNAs in Patients with Amyotrophic Lateral Sclerosis |
| Q38115783 | The complexity, function and applications of RNA in circulation |
| Q92066121 | Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology |
| Q37459974 | Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1. |
| Q38255744 | What do mouse models of muscular dystrophy tell us about the DAPC and its components? |
| Q96136132 | miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophy |
| Q55002428 | miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context. |
Search more.